Psychotropic co-medication among stimulant-treated children in The Netherlands

被引:29
作者
Faber, A [1 ]
de Jong-van den Berg, LTW [1 ]
van den Berg, PB [1 ]
Tobi, H [1 ]
机构
[1] Univ Groningen, Ctr Pharm, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, GUIDE, NL-9713 AW Groningen, Netherlands
关键词
D O I
10.1089/cap.2005.15.38
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: The aim of this study was to examine stimulant use from 1998 to 2002 among children in the Dutch pediatric population with emphasis on psychotropic co-medication. Methods: A drug utilization study was based on community pharmacy-dispensing data from 1998 to 2002 for children aged 0-19 years in the northern and eastern part of the Netherlands. Results: The prevalence of stimulant use increased from 0.6% in 1998 to 1.2% in 2002. Duration of stimulant treatment was longest in children aged 5-14 years. The use of any psychotropic co-medication in stimulant users increased from 12% in 1998 to nearly 15% in 2002. Of those youths who were prescribed stimulant medication in 2002, the most co-prescribed class was the antipsychotics (7.9%). In 1998, none of the stimulant-treated children received antidepressants for co-medication; in 2002, this was 1.8%. Conclusion: The prevalence of stimulant use among children in the Netherlands has increased in recent years, mainly as a result of the duration of stimulant treatment. Psychotropic co-medication among stimulant-treated children increased moderately.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 14 条
[1]  
[Anonymous], STAT CONFIDENCE
[2]   Licit psychostimulant consumption in Australia, 1984-2000: international and jurisdictional comparison [J].
Berbatis, CG ;
Sunderland, VB ;
Bulsara, M .
MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (10) :539-543
[3]   Trends in combined pharmacotherapy with stimulants for children [J].
Bhatara, VS ;
Feil, M ;
Hoagwood, K ;
Vitiello, B ;
Zima, B .
PSYCHIATRIC SERVICES, 2002, 53 (03) :244-244
[4]   Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system - Individual and facility predictors [J].
Leslie, DL ;
Rosenheck, RA .
MEDICAL CARE, 2001, 39 (09) :923-933
[5]   Multiple pychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care [J].
Martin, A ;
Van Hoof, T ;
Stubbe, D ;
Sherwin, T ;
Scahill, L .
PSYCHIATRIC SERVICES, 2003, 54 (01) :72-77
[6]  
Miller AR, 2001, CAN MED ASSOC J, V165, P1489
[7]   National trends in the use of psychotropic medications by children [J].
Olfson, M ;
Marcus, SC ;
Weissman, MM ;
Jensen, PS .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (05) :514-521
[8]   Use of psychostimulant medication for ADHD in South Australia [J].
Reid, R ;
Hakendorf, P ;
Prosser, B .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (08) :906-913
[9]   Concomitant psychotropic medication for youths [J].
Safer, DJ ;
Zito, JM ;
dosReis, S .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (03) :438-449
[10]  
Safer DJ, 1996, PEDIATRICS, V98, P1084